| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.704 | 0.003 | 0.72 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.72 0.003 DBMET03622 0.643 0.004 DBMET03626 0.689 0.004 DBMET03625 0.649 0.004 DBMET03624 | DBMET03622 | |
| 0.7 | 0.004 | 0.757 | Src kinase inhibitor | 0.757 0.004 DBMET03622 0.624 0.005 DBMET03626 0.658 0.005 DBMET03625 0.606 0.005 DBMET03624 | DBMET03622 | |
| 0.666 | 0.004 | 0.746 | Lck kinase inhibitor | 0.746 0.004 DBMET03622 0.576 0.004 DBMET03626 0.626 0.004 DBMET03625 0.628 0.004 DBMET03624 | DBMET03622 | |
| 0.625 | 0.003 | 0.687 | Protein-tyrosine kinase Lyn inhibitor | 0.687 0.003 DBMET03622 0.584 0.004 DBMET03626 0.598 0.004 DBMET03625 0.596 0.004 DBMET03624 | DBMET03622 | |
| 0.581 | 0.002 | 0.581 | Bcr-Abl kinase inhibitor | 0.522 0.002 DBMET03622 0.463 0.003 DBMET03626 0.565 0.002 DBMET03625 0.377 0.003 DBMET03624 | ||
| 0.573 | 0.003 | 0.635 | T cell inhibitor | 0.635 0.003 DBMET03622 0.519 0.004 DBMET03626 0.531 0.003 DBMET03625 0.561 0.003 DBMET03624 | DBMET03622 | |
| 0.506 | 0.007 | 0.545 | EphB2 antagonist | 0.545 0.005 DBMET03622 0.434 0.013 DBMET03626 0.5 0.007 DBMET03625 0.464 0.009 DBMET03624 | DBMET03622 | |
| 0.491 | 0.005 | 0.492 | MAP kinase kinase 2 inhibitor | 0.492 0.005 DBMET03622 0.438 0.008 DBMET03626 0.445 0.007 DBMET03625 0.291 0.038 DBMET03624 | DBMET03622 | |
| 0.469 | 0.005 | 0.478 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.478 0.005 DBMET03622 0.449 0.007 DBMET03626 0.456 0.006 DBMET03625 0.431 0.009 DBMET03624 | DBMET03622 | |
| 0.471 | 0.02 | 0.578 | Tyrosine kinase inhibitor | 0.578 0.012 DBMET03622 0.443 0.023 DBMET03626 0.415 0.026 DBMET03625 0.307 0.042 DBMET03624 | DBMET03622 | |
| 0.436 | 0.005 | 0.548 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.548 0.005 DBMET03622 0.372 0.007 DBMET03626 0.383 0.006 DBMET03625 0.365 0.007 DBMET03624 | DBMET03622 | |
| 0.436 | 0.005 | 0.548 | Abl kinase inhibitor | 0.548 0.005 DBMET03622 0.372 0.007 DBMET03626 0.381 0.006 DBMET03625 0.365 0.007 DBMET03624 | DBMET03622 | |
| 0.368 | 0.01 | 0.371 | c-Src kinase inhibitor | 0.371 0.01 DBMET03622 0.345 0.012 DBMET03626 0.352 0.012 DBMET03625 0.295 0.018 DBMET03624 | DBMET03622 | |
| 0.352 | 0.017 | 0.401 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.401 0.011 DBMET03622 0.296 0.028 DBMET03626 0.338 0.019 DBMET03625 0.273 0.036 DBMET03624 | DBMET03622 | |
| 0.381 | 0.059 | 0.404 | Angiogenesis inhibitor | 0.404 0.052 DBMET03622 0.344 0.073 DBMET03626 0.386 0.058 DBMET03625 0.305 0.09 DBMET03624 | DBMET03622 | |
| 0.274 | 0.015 | 0.369 | Aurora-A kinase inhibitor | 0.369 0.009 DBMET03622 0.245 0.018 DBMET03626 0.22 0.022 DBMET03625 0.214 0.023 DBMET03624 | DBMET03622 | |
| 0.278 | 0.027 | 0.371 | LIM domain kinase 1 inhibitor | 0.371 0.009 DBMET03622 0.229 0.049 DBMET03626 0.284 0.025 DBMET03625 0.179 0.074 DBMET03624 | DBMET03622 | |
| 0.249 | 0.021 | 0.332 | Cyclin-dependent kinase 7 inhibitor | 0.332 0.008 DBMET03622 0.221 0.027 DBMET03626 0.208 0.031 DBMET03625 0.209 0.031 DBMET03624 | DBMET03622 | |
| 0.239 | 0.023 | 0.361 | Aurora-B kinase inhibitor | 0.361 0.01 DBMET03622 0.175 0.038 DBMET03626 0.153 0.045 DBMET03625 0.119 0.066 DBMET03624 | DBMET03622 | |
| 0.235 | 0.029 | 0.306 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.306 0.018 DBMET03622 0.191 0.039 DBMET03626 0.202 0.036 DBMET03625 0.133 0.061 DBMET03624 | DBMET03622 | |
| 0.229 | 0.026 | 0.319 | Activin receptor-like kinase 2 inhibitor | 0.319 0.01 DBMET03622 0.221 0.028 DBMET03626 0.22 0.029 DBMET03625 0.119 0.097 DBMET03624 | DBMET03622 | |
| 0.217 | 0.02 | 0.293 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.293 0.012 DBMET03622 0.15 0.033 DBMET03626 0.198 0.023 DBMET03625 0.155 0.031 DBMET03624 | DBMET03622 | |
| 0.202 | 0.009 | 0.276 | MAP kinase 11 inhibitor | 0.276 0.005 DBMET03622 0.134 0.021 DBMET03626 0.165 0.014 DBMET03625 0.175 0.013 DBMET03624 | DBMET03622 | |
| 0.197 | 0.005 | 0.223 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.223 0.005 DBMET03622 0.177 0.008 DBMET03626 0.19 0.006 DBMET03625 0.183 0.007 DBMET03624 | DBMET03622 | |
| 0.191 | 0.016 | 0.199 | EphA2 antagonist | 0.199 0.014 DBMET03622 0.178 0.02 DBMET03626 0.175 0.02 DBMET03625 0.168 0.023 DBMET03624 | DBMET03622 | |
| 0.293 | 0.12 | 0.293 | Immunosuppressant | 0.235 0.162 DBMET03622 0.255 0.144 DBMET03626 0.293 0.119 DBMET03625 0.24 0.156 DBMET03624 | ||
| 0.192 | 0.031 | 0.221 | MAP kinase kinase inhibitor | 0.128 0.067 DBMET03622 0.123 0.071 DBMET03626 0.221 0.022 DBMET03625 | DBMET03625 | |
| 0.155 | 0.013 | 0.171 | Fibroblast growth factor 3 antagonist | 0.171 0.01 DBMET03622 0.108 0.028 DBMET03626 0.133 0.019 DBMET03625 0.085 0.045 DBMET03624 | DBMET03622 | |
| 0.141 | 0.015 | 0.147 | Interleukin 12 antagonist | 0.138 0.017 DBMET03622 0.139 0.016 DBMET03626 0.147 0.013 DBMET03625 0.132 0.02 DBMET03624 | DBMET03625 | |
| 0.15 | 0.038 | 0.165 | Platelet activating factor beta antagonist | 0.165 0.033 DBMET03622 0.107 0.058 DBMET03626 0.125 0.048 DBMET03625 0.116 0.053 DBMET03624 | DBMET03622 | |
| 0.155 | 0.054 | 0.246 | Cyclin-dependent kinase inhibitor | 0.246 0.028 DBMET03622 0.134 0.065 DBMET03626 0.134 0.065 DBMET03625 0.106 0.085 DBMET03624 | DBMET03622 | |
| 0.139 | 0.04 | 0.162 | Ephrin antagonist | 0.162 0.034 DBMET03622 0.16 0.034 DBMET03626 0.124 0.048 DBMET03625 0.105 0.059 DBMET03624 | DBMET03622 | |
| 0.152 | 0.063 | 0.192 | Tyrosine-protein kinase receptor antagonist | 0.192 0.044 DBMET03622 0.132 0.076 DBMET03626 0.116 0.091 DBMET03625 | DBMET03622 | |
| 0.143 | 0.057 | 0.179 | Vascular endothelial growth factor antagonist | 0.179 0.045 DBMET03622 0.113 0.073 DBMET03626 0.125 0.065 DBMET03625 | DBMET03622 | |
| 0.137 | 0.053 | 0.174 | Vascular endothelial growth factor 2 antagonist | 0.174 0.042 DBMET03622 0.105 0.069 DBMET03626 0.118 0.061 DBMET03625 | DBMET03622 | |
| 0.128 | 0.047 | 0.148 | Granulocyte macrophage colony stimulating factor antagonist | 0.148 0.038 DBMET03622 0.09 0.085 DBMET03626 0.09 0.085 DBMET03625 | DBMET03622 | |
| 0.129 | 0.058 | 0.129 | Platelet activating factor antagonist | 0.129 0.057 DBMET03622 0.12 0.063 DBMET03625 0.092 0.086 DBMET03624 | ||
| 0.123 | 0.053 | 0.17 | MAP kinase 13 inhibitor | 0.17 0.028 DBMET03622 0.098 0.084 DBMET03626 0.107 0.07 DBMET03625 0.098 0.084 DBMET03624 | DBMET03622 | |
| 0.171 | 0.103 | 0.21 | Antimitotic | 0.21 0.078 DBMET03622 0.179 0.097 DBMET03626 0.187 0.092 DBMET03625 | DBMET03622 | |
| 0.12 | 0.052 | 0.187 | Cyclin-dependent kinase 2 inhibitor | 0.187 0.027 DBMET03622 0.107 0.062 DBMET03626 0.106 0.064 DBMET03625 0.09 0.082 DBMET03624 | DBMET03622 | |
| 0.112 | 0.044 | 0.116 | Phosphodiesterase 7B inhibitor | 0.116 0.041 DBMET03622 0.103 0.053 DBMET03626 0.091 0.069 DBMET03625 | DBMET03622 | |
| 0.135 | 0.073 | 0.147 | Aurora-C kinase inhibitor | 0.147 0.054 DBMET03622 0.129 0.086 DBMET03626 0.126 0.092 DBMET03625 0.124 0.097 DBMET03624 | DBMET03622 | |
| 0.251 | 0.191 | 0.251 | DNA directed DNA polymerase inhibitor | 0.24 0.198 DBMET03625 | ||
| 0.114 | 0.063 | 0.132 | CDK3/cyclin E inhibitor | 0.132 0.041 DBMET03622 0.11 0.07 DBMET03626 0.102 0.084 DBMET03625 0.105 0.079 DBMET03624 | DBMET03622 | |
| 0.106 | 0.055 | 0.143 | Hedgehog signaling inhibitor | 0.143 0.026 DBMET03622 0.097 0.071 DBMET03625 0.09 0.085 DBMET03624 | DBMET03622 | |
| 0.077 | 0.028 | 0.094 | Phosphodiesterase VII inhibitor | 0.094 0.015 DBMET03622 0.067 0.038 DBMET03626 0.066 0.04 DBMET03625 0.063 0.042 DBMET03624 | DBMET03622 | |
| 0.102 | 0.054 | 0.104 | MAP kinase kinase 1 inhibitor | 0.104 0.052 DBMET03625 | DBMET03625 | |
| 0.138 | 0.09 | 0.143 | MAP kinase kinase 4 inhibitor | 0.127 0.124 DBMET03622 0.135 0.1 DBMET03626 0.143 0.076 DBMET03625 | DBMET03625 | |
| 0.104 | 0.056 | 0.104 | Insulin receptor antagonist | |||
| 0.074 | 0.027 | 0.09 | Cyclin-dependent kinase 6 inhibitor | 0.09 0.014 DBMET03622 0.062 0.039 DBMET03626 0.058 0.044 DBMET03625 0.055 0.047 DBMET03624 | DBMET03622 | |
| 0.087 | 0.042 | 0.145 | Vanilloid antagonist | 0.145 0.022 DBMET03622 0.135 0.024 DBMET03626 0.083 0.045 DBMET03625 | DBMET03622 | |
| 0.096 | 0.055 | 0.139 | CDK/cyclin complex inhibitor | 0.139 0.033 DBMET03622 0.087 0.062 DBMET03626 0.087 0.062 DBMET03625 | DBMET03622 | |
| 0.128 | 0.087 | 0.151 | Death-associated protein kinase 1 inhibitor | 0.151 0.038 DBMET03622 0.123 0.104 DBMET03626 0.13 0.081 DBMET03625 0.122 0.106 DBMET03624 | DBMET03622 | |
| 0.177 | 0.137 | 0.189 | MAP-kinase-activated kinase 5 inhibitor | 0.189 0.118 DBMET03622 0.175 0.14 DBMET03625 | DBMET03622 | |
| 0.115 | 0.076 | 0.151 | MAP kinase 12 inhibitor | 0.151 0.041 DBMET03622 0.101 0.097 DBMET03626 0.102 0.096 DBMET03625 | DBMET03622 | |
| 0.131 | 0.093 | 0.165 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.165 0.062 DBMET03622 0.13 0.094 DBMET03625 | DBMET03622 | |
| 0.067 | 0.032 | 0.086 | Tyrosine-protein kinase EMT inhibitor | 0.086 0.023 DBMET03622 0.06 0.038 DBMET03626 0.053 0.044 DBMET03625 | DBMET03622 | |
| 0.155 | 0.13 | 0.161 | Growth factor agonist | 0.161 0.118 DBMET03622 0.151 0.139 DBMET03626 0.152 0.136 DBMET03625 | DBMET03622 | |
| 0.152 | 0.127 | 0.223 | Platelet aggregation inhibitor | 0.142 0.139 DBMET03625 0.223 0.066 DBMET03624 | DBMET03624 | |
| 0.104 | 0.08 | 0.12 | Interleukin 2 antagonist | 0.12 0.044 DBMET03622 0.102 0.084 DBMET03624 | DBMET03622 | |
| 0.07 | 0.048 | 0.095 | CDK1/cyclin B1 inhibitor | 0.095 0.031 DBMET03622 0.071 0.046 DBMET03626 0.063 0.056 DBMET03625 | DBMET03622 | |
| 0.09 | 0.068 | 0.118 | CDK2/cyclin A inhibitor | 0.118 0.043 DBMET03622 0.081 0.079 DBMET03626 0.086 0.073 DBMET03625 | DBMET03622 | |
| 0.032 | 0.01 | 0.049 | Corticotropin releasing factor 1 receptor antagonist | 0.049 0.005 DBMET03622 0.023 0.016 DBMET03626 0.033 0.009 DBMET03625 0.025 0.013 DBMET03624 | DBMET03622 | |
| 0.06 | 0.038 | 0.082 | CDK4/cyclin D inhibitor | 0.082 0.021 DBMET03622 0.056 0.044 DBMET03626 0.058 0.041 DBMET03625 | DBMET03622 | |
| 0.068 | 0.051 | 0.09 | CDK2/cyclin E2 inhibitor | 0.09 0.032 DBMET03622 0.062 0.059 DBMET03626 | DBMET03622 | |
| 0.06 | 0.051 | 0.101 | Cyclin-dependent kinase 4 inhibitor | 0.101 0.026 DBMET03622 0.058 0.055 DBMET03625 | DBMET03622 | |
| 0.045 | 0.04 | 0.074 | Cyclin E1 inhibitor | 0.074 0.027 DBMET03622 | DBMET03622 | |
| 0.051 | 0.047 | 0.082 | Cyclin E inhibitor | 0.082 0.031 DBMET03622 | DBMET03622 | |
| 0.128 | 0.126 | 0.145 | Antipruritic | 0.145 0.1 DBMET03625 | DBMET03625 | |
| 0.089 | 0.088 | 0.111 | Protein kinase (CK2) alpha inhibitor | 0.097 0.079 DBMET03622 0.111 0.068 DBMET03624 | DBMET03624 | |
| 0.039 | 0.039 | 0.052 | Stearoyl-CoA desaturase inhibitor | 0.045 0.029 DBMET03622 0.052 0.022 DBMET03624 | DBMET03624 | |
| 0.032 | 0.035 | 0.048 | Cyclin D3 inhibitor | 0.048 0.022 DBMET03622 | DBMET03622 | |
| 0.047 | 0.05 | 0.062 | Bruton tyrosine kinase inhibitor | 0.059 0.036 DBMET03622 0.062 0.032 DBMET03626 | DBMET03626 | |
| 0.06 | 0.065 | 0.079 | MAP kinase 14 inhibitor | 0.079 0.048 DBMET03622 | DBMET03622 | |
| 0.046 | 0.053 | 0.071 | CDK4/cyclin D1 inhibitor | 0.071 0.03 DBMET03622 | DBMET03622 | |
| 0.045 | 0.053 | 0.054 | Phosphodiesterase 7A inhibitor | 0.054 0.031 DBMET03622 | DBMET03622 | |
| 0.098 | 0.111 | 0.116 | Phosphodiesterase inhibitor | 0.116 0.087 DBMET03622 0.111 0.092 DBMET03626 | DBMET03622 | |
| 0.069 | 0.082 | 0.088 | Stem cell growth factor agonist | 0.088 0.056 DBMET03622 | DBMET03622 | |
| 0.094 | 0.108 | 0.111 | TRKB antagonist | 0.111 0.086 DBMET03622 | DBMET03622 | |
| 0.09 | 0.104 | 0.113 | TRKA antagonist | 0.113 0.074 DBMET03622 | DBMET03622 | |
| 0.044 | 0.06 | 0.057 | EphB4 antagonist | 0.057 0.041 DBMET03626 | DBMET03626 | |
| 0.039 | 0.055 | 0.072 | Neuropeptide Y5 antagonist | 0.072 0.024 DBMET03622 | DBMET03622 | |
| 0.132 | 0.15 | 0.21 | Aryl hydrocarbon receptor agonist | 0.21 0.097 DBMET03622 | DBMET03622 | |
| 0.043 | 0.061 | 0.056 | CDK2/cyclin E inhibitor | 0.056 0.046 DBMET03622 | DBMET03622 | |
| 0.09 | 0.109 | 0.111 | RET inhibitor | 0.111 0.086 DBMET03622 | DBMET03622 | |
| 0.031 | 0.05 | 0.053 | Phosphodiesterase X inhibitor | 0.053 0.025 DBMET03622 | DBMET03622 | |
| 0.031 | 0.05 | 0.053 | Phosphodiesterase 10A inhibitor | 0.053 0.025 DBMET03622 | DBMET03622 | |
| 0.046 | 0.065 | 0.066 | Cyclin B1 inhibitor | 0.066 0.036 DBMET03622 | DBMET03622 | |
| 0.151 | 0.172 | 0.18 | Streptokinase A inhibitor | 0.18 0.146 DBMET03622 | DBMET03622 | |
| 0.026 | 0.054 | 0.033 | Glutamate (mGluR4) agonist | 0.033 0.026 DBMET03624 | DBMET03624 | |
| 0.038 | 0.071 | 0.062 | Tyk2 inhibitor | 0.062 0.047 DBMET03622 | DBMET03622 | |
| 0.108 | 0.141 | 0.134 | MAP3K9 inhibitor | 0.134 0.087 DBMET03626 | DBMET03626 | |
| 0.128 | 0.162 | 0.174 | Dyrk kinase inhibitor | 0.174 0.115 DBMET03622 | DBMET03622 | |
| 0.04 | 0.076 | 0.067 | p38 MAP kinase inhibitor | 0.067 0.047 DBMET03622 | DBMET03622 | |
| 0.038 | 0.076 | 0.052 | Cyclin B inhibitor | 0.052 0.043 DBMET03622 | DBMET03622 | |
| 0.034 | 0.074 | 0.053 | Diacylglycerol O-acyltransferase inhibitor | 0.053 0.032 DBMET03624 | DBMET03624 | |
| 0.036 | 0.08 | 0.052 | Myc inhibitor | 0.052 0.042 DBMET03622 | DBMET03622 | |
| 0.034 | 0.079 | 0.051 | Cyclin B2 inhibitor | 0.051 0.045 DBMET03622 | DBMET03622 | |
| 0.039 | 0.111 | 0.066 | Check point kinase 1 inhibitor | 0.066 0.049 DBMET03622 | DBMET03622 | |
| 0.223 | 0.301 | 0.283 | Antiinflammatory | 0.283 0.231 DBMET03626 0.265 0.251 DBMET03625 | DBMET03626 | |
| 0.071 | 0.153 | 0.114 | Vascular endothelial growth factor 3 antagonist | 0.114 0.102 DBMET03622 | DBMET03622 | |
| 0.061 | 0.144 | 0.103 | Cyclin-dependent kinase 9 inhibitor | 0.103 0.06 DBMET03622 | DBMET03622 | |
| 0.038 | 0.128 | 0.073 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.073 0.057 DBMET03622 | DBMET03622 | |
| 0.191 | 0.289 | 0.364 | Cyclophilin D inhibitor | 0.364 0.113 DBMET03624 | DBMET03624 | |
| 0.035 | 0.165 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | 0.07 0.028 DBMET03622 | DBMET03622 | |
| 0.01 | 0.151 | 0.063 | Secretase gamma inhibitor | 0.063 0.017 DBMET03626 | DBMET03626 | |
| 0.004 | 0.171 | 0.031 | Prostaglandin D2 antagonist | 0.031 0.011 DBMET03624 | DBMET03624 | |
| 0.127 | 0.312 | 0.21 | Antiobesity | 0.21 0.197 DBMET03622 | DBMET03622 | |
| 0.122 | 0.332 | 0.253 | Toll-Like receptor 7 agonist | 0.253 0.145 DBMET03624 | DBMET03624 | |
| 0.117 | 0.342 | 0.244 | Toll-Like receptor agonist | 0.244 0.154 DBMET03624 | DBMET03624 | |
| 0.021 | 0.289 | 0.041 | Alpha 1L adrenoreceptor agonist | 0.041 0.036 DBMET03622 | DBMET03622 | |
| 0.009 | 0.301 | 0.052 | Prostaglandin antagonist | 0.052 0.037 DBMET03624 | DBMET03624 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |